Dr Liu on the Ongoing Investigation of Zidesamtinib in ROS1+ Tumors
Stephen V. Liu, MD, discusses the potential benefits and ongoing investigation of zidesamtinib for patients with ROS1-positive tumors.
Source: onclive.com
Nvl 520 News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Nvl 520. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Nvl 520 Today - Breaking & Trending Today
FDA Grants Breakthrough Therapy Designation to NVL-520 for Metastatic ROS1+ NSCLC
The FDA has granted breakthrough therapy designation to NVL-520 for pretreated, metastatic ROS1-positive non–small cell lung cancer.
Source: onclive.com